Estados Unidos · Plataformas y datos · MarketBeat

Bioventus Q3 Earnings Call Highlights

Publicado por MarketBeat · Estados Unidos hace 1 h

Bioventus (NASDAQ:BVS) reported third-quarter revenue growth of 3% as strength in its Pain Treatments business, Ultrasonics operation and international markets was partly offset…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Bioventus Q3 Earnings Call Highlights

También te puede interesar

Stock market after midterm elections: What S&P 500 history shows

Vertex raises 2026 revenue guidance following mixed Q3 results

Prediction: This Will Be SpaceX’s Stock Price by the End of 2027

US to hold trilateral talks with Ukraine, Russia in Abu Dhabi next week-US official

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

Altitude Minerals Director Acquires Shares and Options

Bioventus Q3 Earnings Call Highlights

Compartir

También te puede interesar

Stock market after midterm elections: What S&P 500 history shows

Vertex raises 2026 revenue guidance following mixed Q3 results

Prediction: This Will Be SpaceX’s Stock Price by the End of 2027

US to hold trilateral talks with Ukraine, Russia in Abu Dhabi next week-US official

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

Altitude Minerals Director Acquires Shares and Options